Strategies to Control Hep C Costs

Mar 17, 2014
In a recent article in HR Magazine, Mary Dorholt discussed tools Accredo offers plan sponsors to help control the rising costs of hep C treatment.
Tags
  • Hepatitis C

While new treatment developments could significantly improve treatment outcomes for hepatitis C patients, they come with unique challenges. Not least among them is the price tag – up to $100,000 for 12 weeks of therapy. These regimens also have unique usage requirements and nonadherence could raise the risk of resistance.

In a recent article in HR Magazine, Mary Dorholt discussed all the tools Accredo offers plan sponsors to help control the rising costs of hep C treatment while ensuring optimal outcomes for patients. The range of strategies include:

Click to read the full article.

Author Bio

Lab Staff
comments powered by Disqus